021-51111890
购物车（）
sales@molnova.cn
Stiripentol
CAS No. 49763-96-4
Stiripentol ( BCX2600 )
产品货号. M18654 CAS No. 49763-96-4
Stiripentol (STP) is an anticonvulsant agent, which can inhibit N-demethylation of CLB to NCLB mediated by CYP3A4 (noncompetitively) and CYP2C19 (competitively) with Ki of 1.59/0.516 μM and IC50 of 1.58/3.29 μM, respectively.
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥381 | 有现货 |
|
| 10MG | ￥608 | 有现货 |
|
| 25MG | ￥1239 | 有现货 |
|
| 50MG | ￥1758 | 有现货 |
|
| 100MG | ￥2973 | 有现货 |
|
| 200MG | ￥4398 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Stiripentol
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Stiripentol (STP) is an anticonvulsant agent, which can inhibit N-demethylation of CLB to NCLB mediated by CYP3A4 (noncompetitively) and CYP2C19 (competitively) with Ki of 1.59/0.516 μM and IC50 of 1.58/3.29 μM, respectively.
-
产品描述Stiripentol (STP) is an anticonvulsant agent, which can inhibit N-demethylation of CLB to NCLB mediated by CYP3A4 (noncompetitively) and CYP2C19 (competitively) with Ki of 1.59/0.516 μM and IC50 of 1.58/3.29 μM, respectively.
-
同义词BCX2600
-
通路Others
-
靶点Other Targets
-
受体CYP3A4; CYP2C19
-
研究领域——
-
适应症——
化学信息
-
CAS Number49763-96-4
-
分子量234.29
-
分子式C14H18O3
-
纯度98%
-
溶解度DMSO : 150 mg/mL 640.23 mM;
-
SMILESCC(C)(C)C(O)\C=C\c1ccc2OCOc2c1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Giraud C, et al. In vitro and in vivo inhibitory effect of stiripentol on clobazam metabolism.Drug Metab Dispos. 2006 Apr;34(4):608-11. Epub 2006 Jan 13.
产品手册
关联产品
-
BDC2.5 mimotope 1040...
This is a effectively agonistic peptide (mimotope) for diabetogenic T cell clone BDC2.5. It can stimulate BDC2.5 cells with cells showing good response to this mimotope. 1040-31 peptide is specific for BDC2.5 TCR Tg+ (transgenic) T cells. This peptide is also known as p31.
-
3,4-Dihydroxyphenyle...
3, 4-Dihydroxyphenylethanol is an active ingredient extracted from the olive.
-
Methyl nomilinate
Methyl nomilinate from citrus can modulate cell cycle regulators to induce cytotoxicity in human colon cancer (SW480) cells in vitro.
